Global Technology Co., Ltd offers the industry‑leading CAS 1036207‑61‑0 ADC Linker (Maleimide‑PEG) that delivers consistent conjugation efficiency, low impurity profiles, and rapid on‑time delivery. Designed for corporate purchasing managers, technical directors, and operations leaders, this product eliminates the typical bottlenecks of high price, low quality, and slow logistics that plague traditional Chinese supply chains.
Get a free technical datasheet and a 5 g sample within 48 hours – no risk, no obligation.
When you source an ADC linker from a generic catalog, you often encounter:
According to a 2025 Pharma Procurement Survey, 37 % of companies reported project delays directly linked to linker supply issues. If your pipeline relies on a stable, high‑purity maleimide‑PEG, these pain points translate into missed market windows and inflated budgets.
| Parameter | Value | Unit | Method |
|---|---|---|---|
| CAS Number | 1036207‑61‑0 | - | N/A |
| Molecular Weight | 5,000‑20,000 | Da | MALDI‑TOF |
| Purity (HPLC) | ≥ 99.5 | % | Reversed‑Phase |
| Solubility | > 50 mg/mL | Water | UV‑Vis |
| pH Stability | 4‑9 | - | Titration |
| Storage | -20 °C | °C | Stability Test |
| Certificate | GMP, ISO 9001, FDA | - | Audit |
BraN-32-CAS-NO.117345-87-6 Acapatamab 14-3-3-protein-inhibitor-(BV02) ADC-manufacturers
1. Oncology ADC Development (US Biotech, 2024) – Replaced a 5‑step conjugation workflow with our maleimide‑PEG, cutting conjugation time from 48 h to 12 h and increasing drug‑to‑antibody ratio (DAR) consistency from 1.8 ± 0.3 to 2.0 ± 0.1. The client reported a 22 % reduction in overall development cost.
2. Radiolabelled Antibody Production (EU Hospital Pharmacy) – Utilized our linker for site‑specific attachment of ^177Lu. Purity of final radioconjugate exceeded 98 % with a half‑life stability > 72 h, meeting EU‑GMP release criteria.
3. Custom PEG Length for Antibody‑Enzyme Conjugates (Asia‑Pacific CRO) – Delivered a 10 kDa PEG‑maleimide within 5 days, enabling a rapid proof‑of‑concept that accelerated the IND filing by 3 months.
“Switching to Global Technology’s maleimide‑PEG cut our conjugation impurity profile from 7 % to 0.8 %. The on‑time delivery allowed us to meet our Phase I IND deadline without extra freight cost.” – Dr. Emily Chen, Senior Process Engineer, NovaBiopharma (USA)
“The GMP batch records and FDA‑aligned CoA gave our QC team confidence during regulatory filing. We saved an estimated $45 K in additional testing.” – Mark Liu, Head of Procurement, BioGenix (Germany)
Our facilities hold certifications: CE, FDA, ISO 9001, GMP, RoHS, VDE, CB, GS, SAA, HACCP/GMP, IPPC. All shipments are compliant with U.S. import regulations (21 CFR 108.40) and EU REACH standards.
The standard MOQ is **5 g** for research‑grade material. For GMP‑grade production, we accept **10 g** increments, with volume discounts starting at 100 g.
Yes. We offer PEG chain lengths from **2 kDa to 20 kDa**. Custom orders are handled by our R&D team within a 7‑day design window.

Every batch undergoes **in‑process HPLC monitoring**, **mass‑spectrometry verification**, and a **full GMP audit**. A detailed CoA is provided with each shipment.
Standard air freight (DAP) reaches the U.S. in **3‑5 business days**. Express courier (DHL) delivers within **48 hours** for samples. We also support **FOB** and **CIF** terms for bulk orders.
Absolutely. Our regulatory affairs team can supply **GMP batch records, stability data, and FDA‑compliant certificates** to accompany your IND filing.
Limited‑time Offer: The first 50 orders placed this month receive **free 5 g sample** and a **10 % discount** on the first bulk purchase. Stock is limited to 2 tons per quarter to guarantee quality.
“The consistency of the maleimide‑PEG allowed us to scale from 5 g to 2 kg without re‑optimizing the conjugation protocol.”
— Dr. Luis Martínez, Process Development Lead, MedTech Solutions (USA)
“Fast sample delivery saved us three weeks of pre‑clinical testing. The cost savings were immediate.”
— Sarah Patel, Procurement Manager, Apex Biologics (Canada)
“Their regulatory package matched our FDA filing schedule perfectly – no extra documentation needed.”
— Dr. Hiroshi Tanaka, Regulatory Affairs, Nippon Pharma (Japan)
“We appreciated the transparent pricing and the 10 % discount on our first bulk order.”
— Carlos Gomez, Operations Manager, BioEurope (Spain)
Dr. Wei Liu, Ph.D. – Senior Technical Director, Global Technology Co., Ltd.
With **15 years** of experience in ADC linker synthesis, Dr. Liu has authored **12 peer‑reviewed papers** on maleimide‑PEG chemistry and led **5 FDA‑approved IND filings**. He oversees the GMP‑certified manufacturing line and directly supports corporate purchasing teams worldwide.
Contact: service@huanqiukeji9.com | Tel: +86 199 4383 0844
© 2026 Global Technology Co., Ltd. All rights reserved. | Privacy Policy